270 related articles for article (PubMed ID: 32097652)
41. Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT.
Wang J; Cai H; Liu Q; Xia Y; Xing L; Zuo Q; Zhang Y; Chen C; Xu K; Yin P; Chen T
Am J Chin Med; 2020; 48(3):703-718. PubMed ID: 32329642
[TBL] [Abstract][Full Text] [Related]
42. AEG-1 activates Wnt/PCP signaling to promote metastasis in tongue squamous cell carcinoma.
Pan Y; Guo X; Yang Z; Chen S; Lei Y; Lin M; Wang L; Feng C; Ke Z
Oncotarget; 2016 Jan; 7(2):2093-104. PubMed ID: 26689985
[TBL] [Abstract][Full Text] [Related]
43. MiR-142-5p Suppresses Lung Cancer Cell Metastasis by Targeting Yin Yang 1 to Regulate Epithelial-Mesenchymal Transition.
Zhang Q; Liu H; Zhang J; Shan L; Yibureyimu B; Nurlan A; Aerxiding P; Luo Q
Cell Reprogram; 2020 Dec; 22(6):328-336. PubMed ID: 33270501
[TBL] [Abstract][Full Text] [Related]
44. ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer.
Zeng Z; Yang H; Xiao S
BMC Cancer; 2018 Oct; 18(1):1020. PubMed ID: 30348114
[TBL] [Abstract][Full Text] [Related]
45. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
[TBL] [Abstract][Full Text] [Related]
46. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
[TBL] [Abstract][Full Text] [Related]
47. Let‑7i‑5p inhibits the proliferation and metastasis of colon cancer cells by targeting kallikrein‑related peptidase 6.
Song J; Wang L; Ma Q; Yang Y; Yang Z; Wang B; He N
Oncol Rep; 2018 Sep; 40(3):1459-1466. PubMed ID: 30015976
[TBL] [Abstract][Full Text] [Related]
48. cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers.
Hong C; Schubert M; Tijhuis AE; Requesens M; Roorda M; van den Brink A; Ruiz LA; Bakker PL; van der Sluis T; Pieters W; Chen M; Wardenaar R; van der Vegt B; Spierings DCJ; de Bruyn M; van Vugt MATM; Foijer F
Nature; 2022 Jul; 607(7918):366-373. PubMed ID: 35705809
[TBL] [Abstract][Full Text] [Related]
49. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
[TBL] [Abstract][Full Text] [Related]
50. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
[TBL] [Abstract][Full Text] [Related]
51. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling.
Zheng X; Chen L; Zhou Y; Wang Q; Zheng Z; Xu B; Wu C; Zhou Q; Hu W; Wu C; Jiang J
Mol Cancer; 2019 Mar; 18(1):47. PubMed ID: 30925892
[TBL] [Abstract][Full Text] [Related]
52. EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2.
Chen S; Youhong T; Tan Y; He Y; Ban Y; Cai J; Li X; Xiong W; Zeng Z; Li G; Yi M; Liu W; Xiang B
Carcinogenesis; 2020 Jul; 41(6):723-733. PubMed ID: 31665243
[TBL] [Abstract][Full Text] [Related]
53. Elevated soluble E-cadherin during the epithelial-mesenchymal transition process and as a diagnostic marker in colorectal cancer.
Zhu S; Zhao G; Zhao X; Zhan X; Cai M; Geng C; Pu Q; Zhao Q; Fu Q; Huang C; Wang Q
Gene; 2020 Sep; 754():144899. PubMed ID: 32544494
[TBL] [Abstract][Full Text] [Related]
54. A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.
Chen D; Cao G; Liu Q
J Cell Mol Med; 2019 Jun; 23(6):4434-4442. PubMed ID: 31020809
[TBL] [Abstract][Full Text] [Related]
55. Metastatic Colorectal Cancer Rewrites Metabolic Program Through a Glut3-YAP-dependent Signaling Circuit.
Kuo CC; Ling HH; Chiang MC; Chung CH; Lee WY; Chu CY; Wu YC; Chen CH; Lai YW; Tsai IL; Cheng CH; Lin CW
Theranostics; 2019; 9(9):2526-2540. PubMed ID: 31131051
[No Abstract] [Full Text] [Related]
56. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
[TBL] [Abstract][Full Text] [Related]
57. HOXD9 promote epithelial-mesenchymal transition and metastasis in colorectal carcinoma.
Liu M; Xiao Y; Tang W; Li J; Hong L; Dai W; Zhang W; Peng Y; Wu X; Wang J; Chen Y; Bai Y; Lin J; Yang Q; Wang Y; Lin Z; Liu S; Xiong J; Wang J; Xiang L
Cancer Med; 2020 Jun; 9(11):3932-3943. PubMed ID: 32281284
[TBL] [Abstract][Full Text] [Related]
58. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE
Zhu P; Yu H; Zhou K; Bai Y; Qi R; Zhang S
J Exp Clin Cancer Res; 2020 Jun; 39(1):113. PubMed ID: 32546278
[TBL] [Abstract][Full Text] [Related]
59. Artificially introduced aneuploid chromosomes assume a conserved position in colon cancer cells.
Sengupta K; Upender MB; Barenboim-Stapleton L; Nguyen QT; Wincovitch SM; Garfield SH; Difilippantonio MJ; Ried T
PLoS One; 2007 Feb; 2(2):e199. PubMed ID: 17332847
[TBL] [Abstract][Full Text] [Related]
60. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
